DONATE

Common lung bacteria team up to evade immune defences

A study led by the Institute for Bioengineering of Catalonia (IBEC) and the Universitat Autònoma de Barcelona (UAB) has uncovered how co-infection by Pseudomonas aeruginosa and Mycobacterium abscessus, two common lung pathogens, can suppress immune responses and worsen outcomes in patients with respiratory diseases. The findings, published today in the journal Virulence, provide new insight into why polymicrobial infections are particularly difficult to treat and open the door to new therapeutic strategies.

“Explainable” AI cracks secret language of sticky proteins

The new AI is able to predict when and why protein aggregation occurs, a mechanism linked to Alzheimer’s and 50 other diseases that affect 500 million people. The results show great potential for research into neurodegenerative diseases and for improving drug production, reducing costs and increasing efficiency. The study, published today in Science Avances, is the result of a collaboration between the Centre for Genomic Regulation (CRG) and the Institute of Bioengineering of Catalonia (IBEC).

New advances in the fight against the most common form of lung cancer

From left to right, Fernando Martín and Joan Montero at the Faculty of Medicine and Health Sciences. / Credit: University of Barcelona

A study led by the University of Barcelona in collaboraiton with the Institute for Bioengineering of Catalonia reveals that the functional assay dynamic BH3 profiling (DBP) can predict whether specific treatments will be effective in non-small cell lung cancer patients. The technique helps determine which therapy will be most effective by testing it directly on living cells, improving personalised therapies.

IBEC researcher Irene Marco-Rius receives Anatole Abragam Prize for her contributions to the field of magnetic resonance

Dr Irene Marco-Rius, principal investigator at the Institute for Bioengineering of Catalonia (IBEC), has been awarded the 2025 Anatole Abragam Prize for her pioneering work on the use of magnetic resonance to study cells grown on chips, allowing ex vivo metabolic assessment of disease mechanisms and therapy responses in controlled microenvironments. The award was presented at the Joint ENC-ISMAR Conference in California.

IBEC to co-organise the 4th GIPS Annual Conference

Today, Josep Samitier, Director of the Institute for Bioengineering of Catalonia, and Clara Prats, President of the Interdisciplinary Group of Health Professionals (GIPS), signed a collaboration agreement between the two centres to promote translational research in technology and health. As a result, the two institutions will jointly organise the 4th Annual GIPS Conference, which will take place on 17 June.

IBEC and ICMS meet again in Eindhoven for their annual joint symposium

The joint ICMS-IBEC-MPIP symposium took place today, 24 March. The event was jointly organised by the Institute for Bioengineering of Catalonia (IBEC), the Institute for Complex Molecular Systems (ICMS) and the Max Planck Institute for Polymer Research (MPIP). During the day, researchers from the three centres presented their areas of research, with the aim of strengthening the scientific relations between the institutions.

IBEC reinforces its leadership in biomedical innovation at Transfiere 2025

The Institute for Bioengineering of Catalonia took part last week in Transfiere, Europe’s largest R&D and knowledge transfer event. Representatives from the Institute were able to present the Complementary Plan for Biotechnology Applied to Health, the NANOMED Spain platform and the Biobanks and Biomodels Platform (PNBB), all projects coordinated by IBEC.